Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection

Permanent URI for this collectionhttps://hdl.handle.net/11147/7148

Browse

Filters

2020 - 20232

Settings

Scopus Q: search.filters.scopusQuartile.Q2Subject: search.filters.subject.Protein

Search Results

Now showing 1 - 2 of 2
  • Review
    Citation - WoS: 23
    Citation - Scopus: 24
    Microfluidic-Based Technologies for Diagnosis, Prevention, and Treatment of Covid-19: Recent Advances and Future Directions
    (Springer, 2023) Tarım, Ergün Alperay; Anıl İnevi, Müge; Özkan, İlayda; Keçili, Seren; Bilgi, Eyüp; Başlar, Muhammet Semih; Özçivici, Engin; Öksel Karakuş, Ceyda; Tekin, Hüseyin Cumhur
    The COVID-19 pandemic has posed significant challenges to existing healthcare systems around the world. The urgent need for the development of diagnostic and therapeutic strategies for COVID-19 has boomed the demand for new technologies that can improve current healthcare approaches, moving towards more advanced, digitalized, personalized, and patient-oriented systems. Microfluidic-based technologies involve the miniaturization of large-scale devices and laboratory-based procedures, enabling complex chemical and biological operations that are conventionally performed at the macro-scale to be carried out on the microscale or less. The advantages microfluidic systems offer such as rapid, low-cost, accurate, and on-site solutions make these tools extremely useful and effective in the fight against COVID-19. In particular, microfluidic-assisted systems are of great interest in different COVID-19-related domains, varying from direct and indirect detection of COVID-19 infections to drug and vaccine discovery and their targeted delivery. Here, we review recent advances in the use of microfluidic platforms to diagnose, treat or prevent COVID-19. We start by summarizing recent microfluidic-based diagnostic solutions applicable to COVID-19. We then highlight the key roles microfluidics play in developing COVID-19 vaccines and testing how vaccine candidates perform, with a focus on RNA-delivery technologies and nano-carriers. Next, microfluidic-based efforts devoted to assessing the efficacy of potential COVID-19 drugs, either repurposed or new, and their targeted delivery to infected sites are summarized. We conclude by providing future perspectives and research directions that are critical to effectively prevent or respond to future pandemics.
  • Article
    Citation - WoS: 13
    Citation - Scopus: 15
    Analysis of Dilution Induced Disintegration of Micellar Drug Carriers in the Presence of Inter and Intra Micellar Species
    (Elsevier, 2020) Polat, Hürriyet; Kutluay, Gülistan; Polat, Mehmet
    Micelles of self-assembling polymeric surfactant molecules are promising nanoscopic carriers for lipophilic and toxic drugs, genes, and imaging molecules. Though it is a must for successful transport, ensuring micelle integrity is a challenge during intravenous injection where micelles must endure abrupt dilutional effects and encounters with native molecules. Therefore, direct observational evidence of how micelles behave during dilution is valuable in manipulating the designs of these carriers for a succesful drug delivery. Morphology and stability of the barren and a drug-loaded (lipophilic probucol) micelles of a polymeric surfactant (Pluronic® P123) were monitored during systematic re-dilution in distilled water and simulated body fluid in the presence of a model protein (bovine serum albumin). It was observed through surface tension, dynamic light scattering, laser velocimetry, transmission scanning and transmission electron microscopy, and atomic force microscopy analyses that the micelles disintegrated to various degrees in all cases upon dilution. The results indicate that dilution effects must be taken into account in designing micellar drug carriers. The assistance of some other means of protection such as encapsulation should be considered for ensuring micelle integrity within the bloodstream. © 2020 Elsevier B.V.